White Matter Microstructure in Relatives of People with Schizophrenia or Bipolar Disorder: An ENIGMA Meta-Analysis

Why It Matters

The findings clarify that white‑matter abnormalities are not reliable early biomarkers of genetic risk, guiding research toward disease‑progression mechanisms and informing preventive strategies for high‑risk families.

Key Takeaways

• BD relatives show increased FA in posterior limb of internal capsule
• SZ relatives exhibit no significant white‑matter differences versus controls
• Patients with BD/SZ have lower FA across corpus callosum and other tracts
• Higher FA in PLIC may reflect genetic influence on myelination

Pulse Analysis

Large‑scale neuroimaging collaborations like ENIGMA are reshaping our understanding of psychiatric risk by pooling harmonized data from diverse cohorts. By applying a standardized diffusion‑tensor imaging pipeline to over 2,500 participants, the recent meta‑analysis provides unprecedented statistical power to detect subtle white‑matter variations in individuals who share genetics with schizophrenia or bipolar disorder patients but have never manifested the illnesses themselves. This methodological rigor reduces the noise inherent in earlier, smaller studies and enables direct comparison of familial risk signatures against the well‑documented white‑matter deficits observed in diagnosed patients.

The analysis revealed a striking divergence between the two high‑risk groups. First‑degree relatives of bipolar disorder patients exhibited higher FA in the posterior limb of the internal capsule, driven primarily by reduced radial diffusivity, suggesting more efficient myelination in that tract. Conversely, relatives of schizophrenia patients showed no measurable FA differences relative to healthy controls. These results contrast with prior meta‑analyses that reported lower FA in corpus callosum subregions for both groups, highlighting how methodological consistency and larger sample sizes can overturn earlier conclusions. The absence of FA reductions in relatives implies that the white‑matter abnormalities characterizing patients likely emerge after disease onset, possibly due to chronic medication exposure, neuroinflammation, or progressive neurodegeneration.

Clinically, the study underscores the limited utility of white‑matter FA as a pre‑symptomatic biomarker for familial risk, steering attention toward other neurobiological indicators such as functional connectivity or molecular imaging. The observed PLIC elevation in bipolar relatives, however, opens a new avenue for exploring genetic pathways that influence myelination, which could eventually inform targeted preventive interventions. Future longitudinal work in young, high‑risk cohorts will be essential to determine whether these microstructural features precede illness or represent compensatory adaptations, ultimately shaping early‑intervention strategies in psychiatry.